Trailblazer Interviews

1. The CDMO Sourcing Process Has Changed, Samir Panjwani Explains Why & How 9/14/2026

   Samir Panjwani joins me for this edition of the Trailblazers to speak about a new era of CDMO sourcing, and shares examples of the data he discovers and shares in his CDMO Signal that go far beyond capabilities and capacity.

2. Helping Make Cell Therapies Less Expensive & More Available 9/8/2026

   Jerry Jiang, Vice President of Global Sales at CellBri, joins the Trailblazers to speak about how they are working to automate cell therapy processing, how their global footprint is organized to support collaboration with CGT innovators, and the origins of their culture of innovation and how they sustain it.

3. Has A New Cold War Begun? AI, IP, Patents, Drug Discovery, China, And Much More With Joe Renny 9/8/2026

   In his role as Head of Corporate Development at CatSci LTD, Joe Renny applies his wealth of scientific knowledge and global economic insights to address questions that most of the industry is afraid to ask, and he does so in this episode of the Trailblazers.

4. B2B: Baseball To Business With Bob File 8/18/2026

   Bob File joins the Trailblazers to discuss technology, digital transformation & AI, and how life sciences and clinical trials are being impacted. He reminds us that human beings in the loop are the most important feature of AI. Bob is also a former Major League Baseball player, and he shares how his unique journey from professional sports to executive leadership has shaped him in significant ways.

5. Right To Play, Right To Win: Boreal's Business Strategy Story 7/30/2026

   New cell and gene therapy clinical breakthroughs & manufacturing innovations are emerging quickly in a field already characterized by scientific acceleration. It is awfully difficult for CDMOs to effectively communicate their capabilities, let alone establish a new brand in this space. Enter Boreal Biomanufacturing! Eric Lee, General Manger, shares his and Boreal’s story, the challenges they faced, and the strategy they used to develop their new brand.

6. AI & Marketing Are Merging To Create A New Wild West In B2B 7/15/2026

   Artur Tkachev and Seth Preston, Co-Founders of Inf//uent Life Sciences Marketing, join Perry Rearick for the latest edition of the Trailblazers. Disapointing results have B2B solution providers questioning the effectiveness of traditional digital marketing, like email and organic website traffic. Vast amounts of time and resources are wasted trying to address the symptoms and there is little progress on addressing the real underlying problems. The game has changed and B2B buying teams supported by AI agents are operating differently. Sellers must adapt!

7. The Catalent Story With John Chiminski 6/18/2026

   The story of Catalent is one for the ages, an epic tale of growth and the establishment of what we now know as the modern pharmaceutical contract development and manufacturing organization. John Chiminski served as the CEO for fourteen extraordinary years and tells the Catalent story in this episode of the Trailblazers.

8. Why Start-Ups Fail And What Business Leaders Can Do About It 6/4/2026

   Claire Martel is Co-Founder, CEO and President of Murdock-Martell, a finance, accounting and human resources firm that works with some of the most innovative life sciences and technology startups. In this edition of the Trailblazers, she shares her insights into the root causes leading to start-up failure and what innovators should do to avoid them.

9. Real B2B Marketing, No Artificial Ingredients 5/27/2026

   Greg Ippolito, President & Creative Director at Ippolito Media Arts, IMA, is back in this episode of the Trailblazers. He speaks about a new type of silo that is appearing in B2B solution provider companies that results in fragmented marketing plans and has businesses questioning their ROI, and the ever-growing B2B buyer team.

10. Special Edition - CEO Roundtable 4/2/2026

    Rick Hancock, CEO, Argonaut Manufacturing Services; Tim Lowery, CEO, KBI Biopharma & President, JSR Life Sciences; & Tim Mitchell, CEO Sentry Biopharma Services join me for this edition of the Trailblazers to talk about the tri-partnership they have formed, the trends they expect in the pharma industry this year and beyond, and they also offer some sage advice on executive leadership.